These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29146382)

  • 21. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
    Wu S; Pan Y; Zhang X; Zhang L; Duan W; Ma C; Zhang Y; Zhang M; Sun Y; Yang P; Wang Q; Ma J
    Vaccine; 2018 Sep; 36(38):5774-5780. PubMed ID: 30087046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating the case-positive, control test-negative study design for influenza vaccine effectiveness for the frailty bias.
    Talbot HK; Nian H; Chen Q; Zhu Y; Edwards KM; Griffin MR
    Vaccine; 2016 Apr; 34(15):1806-9. PubMed ID: 26930368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: a test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Exindari M; Gioula G; Pogka V; Malisiovas N; Mentis A
    Vaccine; 2015 Jan; 33(2):367-73. PubMed ID: 25448097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States.
    Turbyfill C; Adams K; Tenforde MW; Murray NL; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Keipp Talbot H; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Clark Files D; Hager DN; Shehu A; Prekker ME; Frosch AE; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Lauring AS; Khan A; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; June Gordon A; Qadir N; Chang SY; Mallow C; Rivas C; Kwon JH; Halasa N; Chappell JD; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Rhoads JP; Lindsell CJ; Hart KW; McMorrow M; Surie D; Self WH; Patel MM
    Vaccine; 2022 Nov; 40(48):6979-6986. PubMed ID: 36374708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany.
    Remschmidt C; Rieck T; Bödeker B; Wichmann O
    BMC Infect Dis; 2015 Mar; 15():137. PubMed ID: 25887460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness.
    Sullivan SG; Tchetgen Tchetgen EJ; Cowling BJ
    Am J Epidemiol; 2016 Sep; 184(5):345-53. PubMed ID: 27587721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15.
    Ferdinands JM; Fry AM; Reynolds S; Petrie J; Flannery B; Jackson ML; Belongia EA
    Clin Infect Dis; 2017 Mar; 64(5):544-550. PubMed ID: 28039340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of inactivated quadrivalent influenza vaccine in the 2015/2016 season as assessed in both a test-negative case-control study design and a traditional case-control study design.
    Kimiya T; Shinjoh M; Anzo M; Takahashi H; Sekiguchi S; Sugaya N; Takahashi T
    Eur J Pediatr; 2018 Jul; 177(7):1009-1017. PubMed ID: 29680993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
    Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J;
    Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia.
    Carville KS; Grant KA; Sullivan SG; Fielding JE; Lane CR; Franklin L; Druce J; Kelly HA
    Vaccine; 2015 Jan; 33(2):341-5. PubMed ID: 25448093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating Influenza Vaccine Effectiveness With the Test-Negative Design Using Alternative Control Groups: A Systematic Review and Meta-Analysis.
    Feng S; Cowling BJ; Kelly H; Sullivan SG
    Am J Epidemiol; 2018 Feb; 187(2):389-397. PubMed ID: 28641373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Challenges in estimating influenza vaccine effectiveness.
    Ainslie KEC; Haber M; Orenstein WA
    Expert Rev Vaccines; 2019 Jun; 18(6):615-628. PubMed ID: 31116070
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States.
    Cowling BJ; Feng S; Finelli L; Steffens A; Fowlkes A
    Vaccine; 2016 Jan; 34(1):61-6. PubMed ID: 26611200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan.
    Saito N; Komori K; Suzuki M; Morimoto K; Kishikawa T; Yasaka T; Ariyoshi K
    Vaccine; 2017 Jan; 35(4):687-693. PubMed ID: 28043738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basic principle of population-based cohort study to evaluate influenza vaccine effectiveness among elderly Japanese.
    Hara M; Hirota Y
    Vaccine; 2017 Aug; 35(36):4791-4795. PubMed ID: 28818470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectiveness.
    De Smedt T; Merrall E; Macina D; Perez-Vilar S; Andrews N; Bollaerts K
    PLoS One; 2018; 13(6):e0199180. PubMed ID: 29906276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review.
    Remschmidt C; Wichmann O; Harder T
    BMC Infect Dis; 2015 Oct; 15():429. PubMed ID: 26474974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling the Impacts of Clinical Influenza Testing on Influenza Vaccine Effectiveness Estimates.
    Feldstein LR; Ferdinands JM; Self WH; Randolph AG; Aboodi M; Baughman AH; Brown SM; Exline MC; Clark Files D; Gibbs K; Ginde AA; Gong MN; Grijalva CG; Halasa N; Khan A; Lindsell CJ; Newhams M; Peltan ID; Prekker ME; Rice TW; Shapiro NI; Steingrub J; Talbot HK; Halloran ME; Patel M
    J Infect Dis; 2021 Dec; 224(12):2035-2042. PubMed ID: 34013330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons.
    Jackson ML; Jackson LA; Kieke B; McClure D; Gaglani M; Murthy K; Malosh R; Monto A; Zimmerman RK; Foppa IM; Flannery B; Thompson MG
    Vaccine; 2015 Sep; 33(39):5181-7. PubMed ID: 26271827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.